SIRT6 and metabolic dysfunction-associated steatohepatitis: We and others previously reported that hepatic deletion of Sirt6 promoted alcoholic and nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), and fibrosis (10, 12–14).